$0.7000
At close: Dec 16, 7:16 PM EDT
$0.7099
0.009901.41%
After Hours: 7:16 PM EDT
Comments
Loading...
Unicycive Therapeutics (UNCY) Forecast
NewsEarningsUnicycive Therapeutics (UNCY) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestUnicycive Therapeutics (NASDAQ:UNCY) Stock Quotes, Forecast and News Summary
Unicycive Therapeutics Stock (NASDAQ: UNCY) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Unicycive Therapeutics (UNCY) stock?
You can purchase shares of Unicycive Therapeutics (NASDAQ:UNCY) through any online brokerage.
Who are Unicycive Therapeutics (UNCY) competitors?
Other companies in Unicycive Therapeutics’s space includes: Burning Rock Biotech (NASDAQ:BNR), Armata Pharmaceuticals (AMEX:ARMP), Citius Oncology (NASDAQ:CTOR), Vistagen Therapeutics (NASDAQ:VTGN) and Adicet Bio (NASDAQ:ACET).
What is the forecast, or price target, for Unicycive Therapeutics (UNCY) stock?
Unicycive Therapeutics has a consensus price target of $5.50.
What is the current price for Unicycive Therapeutics (UNCY)?
The stock price for Unicycive Therapeutics (NASDAQ: UNCY) is $0.7099 last updated December 16, 2024 at 7:16 PM EST.
Does Unicycive Therapeutics (UNCY) pay a dividend?
There are no upcoming dividends for Unicycive Therapeutics.
When is Unicycive Therapeutics (NASDAQ:UNCY) reporting earnings?
Unicycive Therapeutics’s Q3 earnings are confirmed for Wednesday, November 13, 2024.
Is Unicycive Therapeutics (UNCY) going to split?
There is no upcoming split for Unicycive Therapeutics.
What sector and industry does Unicycive Therapeutics (UNCY) operate in?
Unicycive Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.